2Steiner DF,Rouille Y,Gong Q et al.The role of prohormone convertase in insulin biosynthesis:evidence for inherited defects in their actipn in man and experimental animals.Diabetes Metab,1996,22:94.
3Ang J,Xu J,Finnerty J et al. The prohormone convertase enzyme 2 (PC2) is essential for processing pro-islet amyloid polypeptidase at the NH2-terminal cleavage site.Diabetes,2001,50:534.
4Hostens K, Ling Z,Van Schravendijk C et al.Prolonged exposure of human beta-cell to high glucose increases their release of proinsulin during acute stimulation with glucose or arginine.J Clin Endocrinol Metab,1999,84:1386.
5Urukawa H,Carroll RJ,Swift HH et al.Long-term elevation of free fatty acids leads to delayed processing of proinsulin and prohormone convertases 2 and 3 in the pancreatic beta-cell line MIN6.Diabetes,1999,48:1395.
6Kahn SE,Halban PA.Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM.Diabetes,1997,46:1725.
7Ohagi S,Sakaguchi H,Sanke T et al.Human prohormone convertase 3 gene:exon-intron organization and molecular scanning for mutations in Japanese subjects with NIDDM.Diabetes,1996,45:897.
8Yoshida H,Ohagl S,Sanke T.Association of the prohormone convertase 2 gene on chromosome 20 with NIDDM in Japanese subject.Diabetes,1995,44:389.
10Utsunomiya N,Ohagi S,Sanke T et al.Organization of the human carboxypeptidase E gene and molecular scanning for mutation in Japanese subjects with NIDDM or obesity.Diabetologia,1998,41:701.
6Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio heart study[J]. Diabetes Care, 1997;20(7):1087-92.
7Rachman J, Levy JC, Barrow BA, et al.Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy[J].Diabetes, 1997;46(10):1557-62.
8Kahn SE, Halban PA. Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM[J].Diabetes, 1997;46(11): 1725-32.
9Saad MF, Kahn SE, Nelson RG. et al .Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus[J]. J Clin Endocrinol Metab,1990;70(5):1247-53.
10Coifman R, Dalbosco IS, Russo EMK,et al .Specific insulin and proinsulin in normal glucose tolerant first-degree relatives of NIDDM patients[J].Braz J Med Biol Res, 1999;32(1):67-72.
2BENZINOU M, WALLEY A J, MEYRE D, et al. Common nonsynonymous variants in PCSK1 confer risk of obesity[J]. Nature Genetics, 2008, 40(8): 943-945.
3STEINER D F. The proprotein convertases[J]. Current Opinion in Chemical Biology, 1998, 2(1): 31-39.
4LLOYD D J, BOHAN S, GEKAKIS N. Obesity, hyperphagia and increased metabolic efficiency in PCI mutant mice [J]. Human Molecular Genetics, 2006, 15(11): 1884-1893.
5LU H F, YANG Y, ALLISTER E M, et al. The identification of potential factors associated with the development of Type 2 Dia- betes[J]. Molecullar & Cellular Proteomics, 2008, 7(8): 1434- 1451.
6WANG J, XU J, FINNERTY J, et al. The prohormone conver- tase enzyme 2 (PC2) is essential for processing pro-islet amy- loid polypeptide at the NH2-terminal cleavage site[J]. Diabetes, 2001, 50(3): 534-539.
7MARZBAN L, TRIGO-GONZALEZ G, VERCHERE C B. Role of,β-cell prohormone convertase (PC)1/3 in processing of pro- islet amyloid polypeptide[J]. Diabetes, 2004, 53 (1): 141 - 148.
8FAROOQI I S, VOLDERS K, STANHOPE R, et al. Hyperpha- gia and early-onset obesity due to a novel homozygous mis- sense mutation in prohormone convertase 1/3 [J]. Endocrine Society, 2007, 92(9): 3369-3373.
9ZHU X, ZHOU A, DEY A, et al. Disruption of PC1/3 expres- sion in mice causes dwarfism and multiple neuroendoerine peptide processing defects[J]. Proceedings of the National A- cademy of Science of the United States of America, 2002, 99 (16): 10293-10298.
10WEN J H, CHEN Y Y, SONG S J, et al. Paired box 6 (PAX6) regulates glucose metabolism via proinsulin proceeding medi- ated by prohonnone convertase 1/3 (PC1/3)[J]. Diabetologia, 2009, 52(3): 504-513.
